Illumina Reaches New 52-Week High (ILMN)
NEW YORK (
) --
(Nasdaq:
) hit a new 52-week high Friday as it is currently trading at $77.61, above its previous 52-week high of $77.14 with 373,158 shares traded as of 10:20 a.m. ET. Average volume has been 1.4 million shares over the past 30 days.
Illumina has a market cap of $9.28 billion and is part of the health care sector and drugs industry. Shares are up 34.2% year to date as of the close of trading on Thursday.
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates
Illumina
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
.
See all
52-week high stocks
or get investment ideas from our
.
.
null